DHG Pharmaceutical Future Growth
Future criteria checks 2/6
DHG Pharmaceutical is forecast to grow earnings and revenue by 11.8% and 6.7% per annum respectively. EPS is expected to grow by 11% per annum. Return on equity is forecast to be 22.5% in 3 years.
Key information
11.8%
Earnings growth rate
11.0%
EPS growth rate
Pharmaceuticals earnings growth | 16.8% |
Revenue growth rate | 6.7% |
Future return on equity | 22.5% |
Analyst coverage | Low |
Last updated | 01 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 5,859,300 | 1,149,400 | 885,600 | 985,600 | 1 |
12/31/2025 | 5,522,900 | 1,082,200 | 748,100 | 848,100 | 1 |
12/31/2024 | 5,263,100 | 1,036,400 | 932,500 | 1,032,500 | 1 |
9/30/2024 | 4,960,915 | 804,086 | 842,908 | 1,002,471 | N/A |
6/30/2024 | 4,998,538 | 814,146 | 449,908 | 768,976 | N/A |
3/31/2024 | 5,045,356 | 884,696 | 161,636 | 625,825 | N/A |
12/31/2023 | 5,015,395 | 1,017,143 | -246,171 | 240,171 | N/A |
9/30/2023 | 4,810,958 | 993,775 | -152,847 | 279,879 | N/A |
6/30/2023 | 4,873,182 | 1,090,086 | 187,342 | 507,525 | N/A |
3/31/2023 | 4,839,799 | 1,058,431 | 375,441 | 639,936 | N/A |
12/31/2022 | 4,676,016 | 956,801 | 667,293 | 901,285 | N/A |
9/30/2022 | 4,439,228 | 892,071 | 509,359 | 687,463 | N/A |
6/30/2022 | 4,221,993 | 830,993 | 581,043 | 708,163 | N/A |
3/31/2022 | 4,050,562 | 798,323 | 576,051 | 600,911 | N/A |
12/31/2021 | 4,003,170 | 747,903 | 427,882 | 452,444 | N/A |
9/30/2021 | 4,121,504 | 787,063 | 741,594 | 810,473 | N/A |
6/30/2021 | 4,042,091 | 752,087 | 692,118 | 756,815 | N/A |
3/31/2021 | 3,914,547 | 737,784 | 579,217 | 641,854 | N/A |
12/31/2020 | 3,755,619 | 711,679 | 737,369 | 826,174 | N/A |
9/30/2020 | 3,823,169 | 706,750 | 694,520 | 754,410 | N/A |
6/30/2020 | 3,832,489 | 658,089 | 735,896 | 800,342 | N/A |
3/31/2020 | 3,988,019 | 649,948 | 911,056 | 981,352 | N/A |
12/31/2019 | 3,896,754 | 610,326 | 781,139 | 838,240 | N/A |
9/30/2019 | 3,829,823 | 593,646 | 554,277 | 595,279 | N/A |
6/30/2019 | 3,783,556 | 614,656 | 287,027 | 330,589 | N/A |
3/31/2019 | 3,740,890 | 568,033 | 402,552 | 447,769 | N/A |
12/31/2018 | 3,882,128 | 581,921 | 249,946 | 290,791 | N/A |
9/30/2018 | 4,022,342 | 529,246 | 336,266 | 390,054 | N/A |
6/30/2018 | 4,096,274 | 513,625 | N/A | 530,524 | N/A |
3/31/2018 | 4,088,815 | 553,923 | N/A | 372,556 | N/A |
12/31/2017 | 4,062,753 | 572,358 | N/A | 460,308 | N/A |
9/30/2017 | 3,885,199 | 626,590 | N/A | 476,892 | N/A |
6/30/2017 | 3,899,974 | 643,271 | N/A | 456,091 | N/A |
3/31/2017 | 3,849,999 | 605,147 | N/A | 499,087 | N/A |
12/31/2016 | 3,783,045 | 585,715 | N/A | 645,191 | N/A |
9/30/2016 | 3,756,702 | 521,875 | N/A | 625,313 | N/A |
6/30/2016 | 3,830,975 | 528,813 | N/A | 706,092 | N/A |
3/31/2016 | 3,754,089 | 539,435 | N/A | 727,123 | N/A |
12/31/2015 | 3,607,760 | 500,418 | N/A | 475,195 | N/A |
9/30/2015 | 3,770,063 | 468,201 | N/A | 364,628 | N/A |
6/30/2015 | 3,687,376 | 446,703 | N/A | 344,509 | N/A |
3/31/2015 | 3,857,620 | 429,449 | N/A | 307,904 | N/A |
12/31/2014 | 3,912,518 | 450,484 | N/A | 301,305 | N/A |
9/30/2014 | 3,691,476 | 501,717 | N/A | 413,937 | N/A |
6/30/2014 | 3,589,442 | 585,400 | N/A | 386,540 | N/A |
3/31/2014 | 3,344,391 | 591,197 | N/A | 270,989 | N/A |
12/31/2013 | 3,390,797 | 588,960 | N/A | 484,458 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DHG's forecast earnings growth (11.8% per year) is above the savings rate (3%).
Earnings vs Market: DHG's earnings (11.8% per year) are forecast to grow slower than the VN market (20.3% per year).
High Growth Earnings: DHG's earnings are forecast to grow, but not significantly.
Revenue vs Market: DHG's revenue (6.7% per year) is forecast to grow slower than the VN market (17.8% per year).
High Growth Revenue: DHG's revenue (6.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: DHG's Return on Equity is forecast to be high in 3 years time (22.5%)